SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-17-006468
Filing Date
2017-02-03
Accepted
2017-02-03 17:00:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a17-3469_2sc13ga.htm SC 13G/A 55723
  Complete submission text file 0001104659-17-006468.txt   57167
Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Subject) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-88833 | Film No.: 17572858
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address LASHFORD HOUSE, CHURCH LANE DRY SANDFORD ABINGDON, OXFORDSHIRE X0 OX13 6JP
Business Address
Cross Nicholas John (Filed by) CIK: 0001669945 (see all company filings)

Type: SC 13G/A